Category

Insights
COVID Vaccines in Canada

COVID Vaccines in Canada

COVID-19 has changed the entire world. In Medlior’s latest blog post, we look at vaccine development and approval in Canada, answering questions about how the vaccines could be developed so quickly, and what contributed to Canada’s slow start in rolling them out....

Key Highlights From ISPOR 2021

Key Highlights From ISPOR 2021

The ISPOR 2021 annual conference was held last week. As usual, there were numerous insightful and thought-provoking sessions and workshops to attend, aimed at improving health economics and outcomes research (HEOR) research methods. Unsurprisingly, the COVID-19...

Synthetic Data and Real-World Evidence Studies

Synthetic Data and Real-World Evidence Studies

What is Synthetic Data? Synthetic data is the generation of realistic datasets that capture important relationships and information from real-world data. These datasets are created through random sampling models, such as Bayesian or neural networks, with the help of...

Medlior Publications

Medlior Publications

Explore a list of all of Medlior's recent publications including recent Medlior evidence generation publications and recent Medlior RWE publications. Recent Medlior RWE publications Scory T, Chen G, Farris M, Shih YH, Pinto L, Cowling T. Lipid-lowering therapy...

The effects of COVID-19 on Cancer screening

The effects of COVID-19 on Cancer screening

Across the globe, the COVID-19 pandemic has negatively impacted healthcare delivery including: delays in elective or non-urgent surgeries and procedures, disruptions to cancer screening, and cessation of routine laboratory tests. In Canada, the Canadian Institute for...

Looking Forward for 2021

Looking Forward for 2021

In January of 2020, we started the year with a passion for innovation and collaboration to produce impactful health outcomes research projects. We certainly could not have predicted the year that would follow, and while it was unprecedented, it also emphasized the...